Capsule with control member

Information

  • Patent Grant
  • 10611507
  • Patent Number
    10,611,507
  • Date Filed
    Wednesday, August 20, 2014
    9 years ago
  • Date Issued
    Tuesday, April 7, 2020
    4 years ago
Abstract
A capsule is provided for use in a machine for preparing a consumable product from capsules. The capsule includes a body that defines an interior space with an opening. Ingredients are disposed within the interior space for preparing a desired product, a portion of the ingredients being non-permanently bound into a cluster. The cluster acts as a control member for controlling a flow of fluid for a period of time within the capsule. A cover is disposed over the opening.
Description
FIELD

This specification relates to consumable products and in particular to capsules, for use in capsule machines, for preparing a consumable product.


BACKGROUND

The following background discussion is not an admission that anything discussed below is citable as prior art or common general knowledge. The documents listed below are incorporated herein in their entirety by this reference to them.


Single serve capsules for use in machines to prepare a desired consumable product are becoming increasingly popular. Such capsules come in a variety of formats containing ingredients for producing beverages such as coffee, tea, hot chocolate or soup broth.


Capsule machines typically include an injection system for injecting a fluid, such as hot water, into a capsule for mixing with ingredients disposed within the capsule to prepare a desired consumable product. A dispensing system may also be provided to dispense the prepared product from the capsule for delivery to a receptacle such as a user's cup or bowl.


A problem with conventional capsules is that it can be difficult to control the manner in which ingredients are exposed to fluid that is injected into the capsule. It may be desirable for example for certain ingredients to be mixed with fluid within the capsule for a longer period of time than other ingredients. It may also be desirable for certain ingredients to be separated from other ingredients within the capsule prior to, or for a desired period following, injection of fluid into the capsule.


Another problem with conventional capsules is that the fluid injected into the capsule may form one or more channels through the ingredients contained within the capsule along one or more axes of injection. This can result in fluid being dispensed from the capsule prior to adequately mixing with ingredients. Furthermore, some ingredients may not be sufficiently saturated with fluid to optimize the preparation of the desired product.


It is known to provide permanent structural elements within a capsule to manage the flow of fluid that is injected into the capsule. A problem with permanent structural elements is that they add to the cost and complexity of manufacturing the capsule. Permanent structural elements may also occupy space within the capsule which may be better utilized for other purposes.


There is a need for an improved capsule for use in a capsule machine.


SUMMARY

In one aspect the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said capsule comprising:


a body defining an interior space with an opening;


ingredients disposed in said interior space for preparing a desired consumable product, a portion of said ingredients being non-permanently bound into a cluster; and


a cover disposed over said opening.


In another aspect, the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said capsule comprising:


a body defining an interior space with an opening;


ingredients disposed in said interior space for preparing a consumable product, a portion of said ingredients forming a control member for controlling a flow of fluid for a period of time within said capsule; and


a cover disposed over said opening.


Other aspects and features of the teachings disclosed herein will become apparent, to those ordinarily skilled in the art, upon review of the following description of the specific examples of the specification.





DRAWINGS

The drawings included herewith are for illustrating various examples of articles, methods, and apparatuses of the present specification and are not intended to limit the scope of what is taught in any way. For simplicity and clarity of illustration, where considered appropriate, reference numerals may be repeated among the drawings to indicate corresponding or analogous elements.



FIG. 1 is a sectional view of a capsule in accordance with the present invention;



FIGS. 2(a)-2(d) are schematic views of clusters defining control members for a capsule in accordance with the present invention; and



FIG. 3 is a schematic view of a capsule machine for use with a capsule in accordance with the present invention.





DESCRIPTION OF VARIOUS EMBODIMENTS

Various apparatuses or methods will be described below to provide examples of the claimed invention. The claimed invention is not limited to apparatuses or methods having all of the features of any one apparatus or method described below or to features common to multiple or all of the apparatuses described below. The claimed invention may reside in a combination or sub-combination of the apparatus elements or method steps described below. It is possible that an apparatus or method described below is not an example of the claimed invention. The applicant(s), inventor(s) and/or owner(s) reserve all rights in any invention disclosed in an apparatus or method described below that is not claimed in this document and do not abandon, disclaim or dedicate to the public any such invention by its disclosure in this document.


A capsule in accordance with the present invention is shown generally at 10 in the figures. Capsule 10 includes a body 12, filter 14 (when required), ingredients 16 and cover 18. Capsule may be sized to provide a single serving of a desired product or multiple servings.


Ingredients 16 include soluble and/or insoluble ingredients that are a precursor to forming a desired product. Preferably, ingredients 16 are provided in a dry state. Soluble ingredients may include instant coffee, chocolate, soup stock or other ingredients in powdered, crystallized or other forms adapted for solubility or contained within a soluble film or pouch. Insoluble ingredients may include tea leaves, coffee grounds, herbs or other ingredients adapted for forming a consumable product by extraction or infusion. Ingredients 16 may also include active ingredients (eg foaming agents), natural health additives, regulated drugs, alcohol or other soluble or insoluble ingredients.


Ingredients 16 may be disposed in a plurality of distinct regions R1, R2 . . . Rn within capsule 10. The same type of ingredients 16 may be disposed in each region R or different types of ingredients 16 may be disposed in different regions R. The density, cohesion or other physical properties of ingredients 16 may also vary between regions R.


Capsule 10 is sized and configured for use in a machine 20 that is adapted for preparing a product from capsule 10. Machine 20 may include an injection system 22 for injecting a fluid, typically heated water, into the capsule for mixing with ingredients 16. Injection system 22 may include a nozzle 22a disposed on machine 20 that is adapted to pierce cover 18 to inject fluid into capsule 10. Injection system 22 may alternatively have at least one component disposed on capsule 10, such as on cover 18, and adapted to pierce body 12 and interact with machine 20 to inject fluid into capsule 10.


Machine may also include a dispensing system 24 for dispensing product from capsule 10 into a desired receptacle 26 such as a bowl or cup. Dispensing system 24 may include a hollow probe 24a that is adapted to pierce capsule 10 to dispense a prepared product from capsule 10.


Body 12 of capsule 10 includes a sidewall 30 and an end wall 32 together defining an interior space 34. An opening 36 is defined at one end of body 12 and a flange 38 extends around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20.


In another embodiment, body 12 may be formed with no end wall 32 and no sidewall 30 or a partial sidewall 30. Flange 38 may still extend around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20. Filter 14 may be secured to flange 38 or to partial sidewall 30.


Filter 14 is adapted to be disposed within body 12 to define at least one ingredients chamber for receiving one or more ingredients 16 and in particular insoluble ingredients 16 that are not intended to be dispensed into receptacle 26 (for example coffee grounds or tea leaves).


Filter 14 is preferably adapted to be phobic to the fluid being injected into capsule 10. In most instances, the fluid will comprise water (either heated or cooled) and a hydrophobic filter 14 is desired. Filter 14 may be formed of materials that are phobic to fluid such as polyolefins (eg, polyethylene, polypropylene) and mixtures of polyolefins with other polymers or filter 14 may be coated with materials that are phobic to fluid such as a polyethylene coating.


Preferably, filter 14 is formed of a moldable non-woven filtration material that includes a plurality of multi-component fibers that are bound or interlocked by non-woven manufacturing techniques (such as spun bond techniques) to form a web having channels extending from one side of filter 14 to the other. The desired diameter for channels after forming is between 20 and 100 μm, more preferably between 40 to 80 μm. More details of a preferred filtration material for filter 14 are provided in US patent publication 20140127364 which is hereby incorporated in its entirety herein by reference.


Filter 14 may be secured to flange 38 or to an interior surface of capsule 10 (such as to sidewall 30). Capsule 10 may be provided without filter 14 in instances where ingredients are soluble or where it is desired that insoluble ingredients 16 are dispensed together with fluid into receptacle 26 (this requires that dispensing system be adapted to dispense insoluble ingredients 16).


Cover 18 is disposed over opening 36 and secured to body 12 such as by sealing cover 18 directly to flange 38 or indirectly with a portion of filter 14 located between.


A control member 50 may be defined by a cluster 52 of ingredients 16 disposed within capsule 10 as described further below. Control member 50 may comprise a first region R1 of ingredients 16 within capsule 10. The remainder of ingredients 16 for capsule 10 may comprise a second region R2 or capsule 10. Second region R2 may partially or fully surround first region R1. Ingredients 16 in second region R2 may be loosely disposed within capsule while ingredients in first region R1 are contained within cluster 52.


Control member 50 is disposed at a location 54 within capsule 10 that is adapted for controlling the flow of fluid injected into capsule 10. Such fluid control may comprise dispersing a flow of fluid for a period of time, absorbing a flow of fluid for a period of time or otherwise controlling or altering the flow of fluid within capsule 10. Control member 50 comprises a non-permanent structure that is adapted to at least partially dissolve or break apart within capsule when exposed to a flow of fluid over a set period of time (such as the period of time required to inject the desired amount of fluid into capsule 10).


Location 54 is selected according to the type of capsule machine 20 and injection system 22 for which capsule 10 is intended to be used as well as the type of ingredients 16 disposed within capsule 10. Location 54 for K-cup™ brewers for example may be along a central axis A of capsule 10 in line with the flow of fluid that is injected into capsule 10 through injection nozzle 22a. Location 54 may also be along a transverse axis B where cluster 52 is formed as a layer or crust. In some instances it may be desirable for location 54 to be at a lower portion of capsule 10 and in other instances in may be preferable for location 54 to be at an upper location of capsule.


Cluster 52 comprises a portion of ingredients 16 that are non permanently bound together on their own or with the addition of a binder material. Cluster 52 is adapted to at least partially break apart or dissolve over a desired dwell time T within capsule, when exposed to the flow of fluid in a desired manner from a desired injection system 22.


Cluster 52 may be formed by compressing a portion of ingredients 16 by a desired amount as depicted in FIG. 2(a). The compression can be achieved by a compacting device or an auger system with a relatively high taper which delivers a compacted power to a container. The compression may occur during the process of filling capsule with ingredients or it may occur at a prior stage to filling capsule. Cluster 52 of compressed ingredients is adapted to dissolve or break apart over a period of time when exposed to a flow of fluid within capsule. A cluster 52 of compressed ingredients 16 allows a greater amount of ingredients 16 to be disposed within the same space within capsule 10. Cluster 52 (or region R1) has a higher density of ingredients 16 than ingredients disposed outside of cluster 52 in region R2.


Alternatively, cluster 52 may be formed with a desired binder material 56 as depicted in FIG. 2(b). Binder material 56 is preferably in a liquid state. For example, binder material 56 may be a neutral binder material or it may be an active binder material. A neutral binder material does not add any noticeable flavor, odour, sensory, health benefit or function to the consumable product produced from capsule 10 but may combine or agglomerate with a portion of ingredients 16 to form cluster 52. Examples of neutral binder materials include polyethylene glycol, polypropylene glycol, ethyl alcohol etc. An active binder material provides flavor, odour, sensory, health benefit or function to the consumable product and also may combine or agglomerate with a portion of ingredients 16 to form cluster 52. Examples of an active binder material include Ethyl-2-methybutyrate (apple), 1-octen-3-ol, (mushroom), p-menthene-8-thiol (Grapefruit), 5-methyl-2-hepten-4-one (Hazelnut). The active binder is employed either directly at a high concentration or diluted with a neutral material. Both neutral and active binder materials are preferably highly water soluble.


Alternatively, cluster 52 may be formed with a soluble container 58 that is adapted to contain the portion of ingredients 16 as depicted in FIG. 2(c). For example, soluble container 58 may be formed of soluble gels or films, preferably with water-soluble film. The portion of ingredients 16 contained within soluble container 58 may include liquid ingredients (such as a concentrate) or other ingredients that must be kept separated within capsule (such as foaming agents or other active ingredients).


Preferred materials for soluble container 58 include protein or carbohydrate based materials which could be starch based (e.g., amylose film and amylopectin film), protein based (e.g., gelatin film, casein film), polysaccharide based (e.g., pullulan film, cellulose film), alginate sodium film and pectin film, to name a few. For example, the Vivos™ edible water soluble film from MonoSol can be employed as a soluble container 58 for ingredients 16. The dissolution rate of soluble container 58, and thus cluster 52, is dependent on the material type. Within the same type, the dissolution rate is normally slower when having heavier material density or molecular weight. Preferably the film thickness for soluble container 58 is in the range of 10-100 μm, more preferably 20-80 μm and most preferably 30-70 μm.


Alternatively, cluster 52 may be provided as a tablet 60 as illustrated in FIG. 2(d). Tablet 60 may contain active or functional ingredients, which can be separated from the rest of ingredients. For instance, a food flavor in a tablet format can be used in this application to add certain flavor into food product.


Control member 50 is sized to control at least a portion of the flow of fluid injected into capsule 10 to other locations within the capsule. Preferably, for a single serve capsule, a single control member 50 has a width in the range of 1 to 25 millimeters and more preferably in the range of 5 to 15 millimeters. Multiple control members 50 comprising one or more types of clusters 52 may be disposed within capsule 10, in which case each control member 50 may have a smaller size.


While the above description provides examples of one or more processes or apparatuses, it will be appreciated that other processes or apparatuses may be within the scope of the accompanying claims.

Claims
  • 1. A capsule, for use in a machine that is adapted for injecting a fluid into a capsule for preparing a consumable product, said capsule comprising: a body defining an interior space with an opening;a filter disposed in said interior space to define an ingredients chamber;an axis defined through said opening and said ingredients chamber in said body for receiving an injection of fluid from the machine;insoluble ingredients disposed in said ingredients chamber for preparing a desired consumable product by extraction or infusion from the injection of fluid from the machine, a portion of said insoluble ingredients being non-permanently bound into a cluster that is disposed on the line of said axis; anda cover disposed over said opening.
  • 2. The capsule of claim 1, wherein said cluster comprises compressed ingredients.
  • 3. The capsule of claim 1, wherein said cluster includes a binder material that is adapted to bind said portion of ingredients together.
  • 4. The capsule of claim 3 wherein said ingredients are provided in a dry state and said binder material is provided in a liquid state.
  • 5. The capsule of claim 1, wherein said cluster includes a soluble container that is adapted to contain a portion of ingredients.
  • 6. The capsule of claim 1 wherein said cluster includes a tablet that is adapted to contain a portion of ingredients.
  • 7. The capsule of claim 1, wherein said cluster comprises a first region within said ingredients chamber and at least a portion of the remainder of said ingredients comprises a second region within said ingredients chamber.
  • 8. The capsule of claim 7, wherein said second region at least partially surrounds said first region.
  • 9. The capsule of claim 1, wherein said cluster comprises a non-permanent structure that is adapted to at least partially dissolve or break apart within said capsule when exposed to a flow of fluid over a period of time.
  • 10. The capsule of claim 1, wherein said ingredients comprise roast ground coffee.
  • 11. A capsule, for use in a machine that is adapted for injecting a fluid into a capsule for preparing a consumable product, said capsule comprising: a body defining an interior space with an opening;a filter disposed in said interior space to define an ingredients chamber;an axis defined through said opening and said ingredients chamber in said body for receiving an injection of fluid from the machineinsoluble ingredients disposed in said ingredients chamber for preparing a consumable product by extraction or infusion from the injection of fluid from the machine, a portion of said insoluble ingredients forming a control member that is disposed on the line of said axis, wherein said control member comprises a non-permanent structure that is adapted to at least partially dissolve or break apart within said capsule when exposed to the injection of fluid over a period of time; anda cover disposed over said opening.
  • 12. The capsule of claim 11, wherein said control member comprises a cluster formed of compressed ingredients.
  • 13. The capsule of claim 11, wherein said control member comprises a cluster that includes a binder material that is adapted to bind said portion of ingredients together.
  • 14. The capsule of claim 13, wherein said ingredients are provided in a dry state and said binder material is provided in a liquid state.
  • 15. The capsule of claim 11, wherein said control member comprises a soluble container that is adapted to contain said portion of ingredients.
  • 16. The capsule of claim 11, wherein said control member is disposed in a first region within said ingredients chamber and at least a portion of the remainder of said ingredients is disposed in a second region within said ingredients chamber.
  • 17. The capsule of claim 16, wherein said second region at least partially surrounds said first region.
  • 18. The capsule of claim 11, wherein said ingredients comprise roast ground coffee.
  • 19. The capsule of claim 1 wherein said cluster disperses the flow of fluid for a period of time.
  • 20. The capsule of claim 1 wherein said cluster is also disposed along an axis that is transverse to said axis for receiving an injection of fluid from the machine.
  • 21. The capsule of claim 1 wherein said cluster absorbs the flow of fluid for a period of time.
  • 22. The capsule of claim 11 wherein said control member disperses the flow of fluid for a period of time.
  • 23. The capsule of claim 11 wherein said control member absorbs the flow of fluid for a period of time.
US Referenced Citations (245)
Number Name Date Kind
1951357 Hall Mar 1934 A
2113715 Wilcox Apr 1938 A
2987221 Milton Jun 1961 A
3110121 Corrinet Nov 1963 A
3282703 Broadhurst Nov 1966 A
3399806 Lucas Sep 1968 A
3713936 Ramsay Jan 1973 A
4101627 Menier Jul 1978 A
4131064 Ryan et al. Dec 1978 A
4220673 Strobel Sep 1980 A
4235160 Olney et al. Nov 1980 A
4306367 Otto Dec 1981 A
4440796 Lunder et al. Apr 1984 A
4471689 Piana Sep 1984 A
4518639 Phillips May 1985 A
4559729 White Dec 1985 A
4619830 Napier Oct 1986 A
4701365 Iwaski Oct 1987 A
4728425 Sandvig Mar 1988 A
4859337 Woltermann Aug 1989 A
4865737 McMichael Sep 1989 A
4867993 Nordskog Sep 1989 A
4981588 Poulallion Jan 1991 A
4983410 Dinos Jan 1991 A
4995310 van der Lijn et al. Feb 1991 A
4996066 Love et al. Feb 1991 A
5008013 Favre et al. Apr 1991 A
5076433 Howes Dec 1991 A
5298267 Gruenbacher Mar 1994 A
5331793 Pophal et al. Jul 1994 A
5390587 Wu Feb 1995 A
5447631 Mahlich Sep 1995 A
5456929 Mifune et al. Oct 1995 A
5496573 Tsuji et al. Mar 1996 A
5536290 Stark et al. Jul 1996 A
5575383 Seeley Nov 1996 A
5601716 Heinrich et al. Feb 1997 A
5605710 Prindonoff et al. Feb 1997 A
5738786 Winnington-Ingram Apr 1998 A
5806582 Howes Sep 1998 A
5840189 Sylvan et al. Nov 1998 A
5858437 Anson Jan 1999 A
5866185 Burkett Feb 1999 A
5871096 Yakich Feb 1999 A
5871644 Simon et al. Feb 1999 A
5882716 Munz-Schaerer et al. Mar 1999 A
5885314 Oussoren et al. Mar 1999 A
5895672 Cooper Apr 1999 A
5896686 Howes Apr 1999 A
5897899 Fond Apr 1999 A
5923242 Slagle et al. Jul 1999 A
5957279 Howes Sep 1999 A
5971195 Reidinger et al. Oct 1999 A
6025000 Fond et al. Feb 2000 A
6146270 Huard et al. Nov 2000 A
6189438 Bielfeldt et al. Feb 2001 B1
6220147 Priley Apr 2001 B1
6223937 Schmidt May 2001 B1
6440256 Gordon et al. Aug 2002 B1
6514555 Fayard et al. Feb 2003 B1
6548433 Gbur et al. Apr 2003 B1
6557597 Riesterer May 2003 B2
6561232 Frutin May 2003 B1
6589577 Lazaris et al. Jul 2003 B2
6607762 Lazaris et al. Aug 2003 B2
6622615 Heczko Sep 2003 B2
6644173 Lazaris et al. Nov 2003 B2
6645537 Sweeney et al. Nov 2003 B2
6658989 Sweeney et al. Dec 2003 B2
6720070 Hamaguchi et al. Apr 2004 B2
6740345 Cai May 2004 B2
6758130 Sargent et al. Jul 2004 B2
6810788 Hale Nov 2004 B2
6841185 Sargent et al. Jan 2005 B2
6854378 Jarisch et al. Feb 2005 B2
6869627 Perkovic et al. Mar 2005 B2
6913777 Rebhorn et al. Jul 2005 B2
6959832 Sawada Nov 2005 B1
6992586 Rosenfeld Jan 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7153530 Masek et al. Dec 2006 B2
7279188 Arrick et al. Oct 2007 B2
7311209 Bentz et al. Dec 2007 B2
7325479 Laigneau et al. Feb 2008 B2
7328651 Halliday et al. Feb 2008 B2
7387063 Vu et al. Jun 2008 B2
7412921 Hu et al. Aug 2008 B2
7444925 Machlich Nov 2008 B2
7490542 Macchi et al. Feb 2009 B2
7543527 Schmed Jun 2009 B2
7552672 Schmed Jun 2009 B2
7552673 Levin Jun 2009 B2
7624673 Zanetti Jun 2009 B2
7594470 Scarchilli et al. Sep 2009 B2
7640842 Bardazzi Jan 2010 B2
7681492 Suggi et al. Mar 2010 B2
7685930 Mandralis et al. Mar 2010 B2
7698992 Wei Apr 2010 B2
7763300 Sargent et al. Jul 2010 B2
7798055 Mandralis et al. Sep 2010 B2
7854192 Denisart et al. Dec 2010 B2
7856920 Schmed et al. Dec 2010 B2
7856921 Arrick et al. Dec 2010 B2
7910145 Reati Mar 2011 B2
8062682 Mandralis et al. Nov 2011 B2
8225771 Andre Jul 2012 B2
8286547 Lassota Oct 2012 B1
8361527 Winkler et al. Jan 2013 B2
8409646 Yoakim et al. Apr 2013 B2
8425957 Steenhof et al. Apr 2013 B2
8474368 Kilber et al. Jul 2013 B2
8475854 Skalski et al. Jul 2013 B2
8481097 Skalski et al. Jul 2013 B2
8573114 Huang et al. Nov 2013 B2
8591978 Skalski et al. Nov 2013 B2
8673379 Skalski et al. Mar 2014 B2
8740020 Marina et al. Jun 2014 B2
8834948 Estabrook et al. Sep 2014 B2
8960078 Hristov et al. Feb 2015 B2
20020020659 Sweeney et al. Feb 2002 A1
20030005826 Sargent et al. Jan 2003 A1
20030039731 Dalton et al. Feb 2003 A1
20030087005 Baron May 2003 A1
20050016383 Kirschner et al. Jan 2005 A1
20050051478 Karanikos et al. Mar 2005 A1
20050158426 Hu et al. Jul 2005 A1
20050287251 Lazaris et al. Dec 2005 A1
20060236871 Ternite et al. Oct 2006 A1
20060246187 Egolf et al. Nov 2006 A1
20070144356 Rivera Jun 2007 A1
20070148290 Ternite Jun 2007 A1
20070275125 Catani Nov 2007 A1
20080015098 Littlejohn et al. Jan 2008 A1
20080142115 Vogt et al. Jun 2008 A1
20080156196 Doglioni et al. Jul 2008 A1
20080202075 Kronawittleithner et al. Aug 2008 A1
20080245236 Ternite et al. Oct 2008 A1
20090022855 Steenhof et al. Jan 2009 A1
20090110775 Rijskamp et al. Apr 2009 A1
20090133584 De Graaff et al. May 2009 A1
20090165228 Kilkenny Jul 2009 A1
20090175986 Doglioni Majer Jul 2009 A1
20090186141 Almblad et al. Jul 2009 A1
20090206084 Woolf et al. Aug 2009 A1
20090211458 Denisart et al. Aug 2009 A1
20090260690 Bell Oct 2009 A1
20090311389 Zoss et al. Dec 2009 A1
20090324791 Ohresser et al. Dec 2009 A1
20100003379 Zoss et al. Jan 2010 A1
20100028495 Novak et al. Feb 2010 A1
20100116772 Teys May 2010 A1
20100215808 Versini Aug 2010 A1
20100239733 Yoakim et al. Sep 2010 A1
20100303964 Beaulieu et al. Dec 2010 A1
20110003040 Graf et al. Jan 2011 A1
20110033580 Bieshuevel et al. Feb 2011 A1
20110041469 Hale Feb 2011 A1
20110045144 Boussemart et al. Feb 2011 A1
20110076361 Peterson et al. Mar 2011 A1
20110183048 Noble et al. Jul 2011 A1
20110185911 Rapparini Aug 2011 A1
20110247975 Rapparini Oct 2011 A1
20120006205 Vanni Jan 2012 A1
20120024160 Van et al. Feb 2012 A1
20120052163 Doleac et al. Mar 2012 A1
20120070542 Camera et al. Mar 2012 A1
20120097602 Tedford Apr 2012 A1
20120100264 Bucher et al. Apr 2012 A1
20120114825 Imison May 2012 A1
20120121764 Lai et al. May 2012 A1
20120171334 Yoakim Jul 2012 A1
20120174794 Fraij Jul 2012 A1
20120180670 Yoakim Jul 2012 A1
20120180671 Baudet Jul 2012 A1
20120183649 Burkhalter Jul 2012 A1
20120186457 Ozanne Jul 2012 A1
20120196008 York Aug 2012 A1
20120199007 Larzul Aug 2012 A1
20120199010 Mariller Aug 2012 A1
20120199011 Cheng Aug 2012 A1
20120201933 Dran et al. Aug 2012 A1
20120207893 Kreuger Aug 2012 A1
20120207894 Webster Aug 2012 A1
20120210876 Glucksman Aug 2012 A1
20120210878 Mariller Aug 2012 A1
20120210879 Mariller Aug 2012 A1
20120231123 Kamerbeek Sep 2012 A1
20120231124 Kamerbeek Sep 2012 A1
20120231126 Lo Faro Sep 2012 A1
20120231133 Kamerbeek Sep 2012 A1
20120251668 Wong Oct 2012 A1
20120251669 Kamerbeek Oct 2012 A1
20120251670 Kamerbeek Oct 2012 A1
20120251671 Kamerbeek Oct 2012 A1
20120251692 Kamerbeek Oct 2012 A1
20120251693 Kamerbeek Oct 2012 A1
20120251694 Kamerbeek Oct 2012 A1
20120258204 Tsuji Oct 2012 A1
20120258210 Wong Oct 2012 A1
20120258219 Wong Oct 2012 A1
20120258221 Wong Oct 2012 A1
20120260806 Rolfes Oct 2012 A1
20120263829 Kamerbeek Oct 2012 A1
20120263830 Kamerbeek Oct 2012 A1
20120263833 Wong Oct 2012 A1
20120266755 Baudet Oct 2012 A1
20120269933 Rapparini Oct 2012 A1
20120272830 Gugerli Nov 2012 A1
20120276252 Bunke Nov 2012 A1
20120276255 Verbeek Nov 2012 A1
20120297987 Lee Nov 2012 A1
20120301581 Abegglen Nov 2012 A1
20120307024 Howes Dec 2012 A1
20120308688 Peterson Dec 2012 A1
20120312174 Lambert Dec 2012 A1
20120321755 Macaulay Dec 2012 A1
20120321756 Estabrook et al. Dec 2012 A1
20120328739 Nocera Dec 2012 A1
20120328740 Nocera Dec 2012 A1
20120328744 Nocera Dec 2012 A1
20130004629 Clark Jan 2013 A1
20130004637 Gugerli Jan 2013 A1
20130008316 Hoeglauer Jan 2013 A1
20130011521 Weijers et al. Jan 2013 A1
20130017303 Vu Jan 2013 A1
20130025466 Fu Jan 2013 A1
20130032034 Jarisch Feb 2013 A1
20130047863 Larzul Feb 2013 A1
20130059039 Trombetta Mar 2013 A1
20130059903 Deuber Mar 2013 A1
20130068109 Pribus et al. Mar 2013 A1
20130084368 Linck et al. Apr 2013 A1
20130095219 de Graaff et al. Apr 2013 A1
20130115342 Van et al. May 2013 A1
20130122153 Ferrier et al. May 2013 A1
20130122167 Winkler et al. May 2013 A1
20130142931 Fin et al. Jun 2013 A1
20130259982 Abegglen et al. Oct 2013 A1
20130340626 Oh Dec 2013 A1
20130344205 Oh Dec 2013 A1
20140013958 Krasne et al. Jan 2014 A1
20140037802 Cardoso Feb 2014 A1
20140099388 Wang et al. Apr 2014 A1
20140106036 Cardoso Apr 2014 A1
20150050391 Rapparini Feb 2015 A1
Foreign Referenced Citations (43)
Number Date Country
2012891 Sep 1991 CA
2276927 Jan 2000 CA
2517840 Apr 2004 CA
2516417 Sep 2004 CA
2689804 Mar 2008 CA
2686347 Dec 2008 CA
2807489 Feb 2012 CA
2824199 Aug 2012 CA
2759782 Nov 2012 CA
2801236 Mar 2013 CA
202537195 Nov 2012 CN
202960136 Jun 2013 CN
0047169 Mar 1982 EP
0145499 Jun 1985 EP
0432126 Jun 1991 EP
1593329 Nov 2005 EP
1859683 Nov 2007 EP
2230195 Sep 2010 EP
2345351 Jul 2011 EP
2409608 Jan 2012 EP
1208782 Aug 2014 EP
2930522 Oct 2009 FR
803486 Oct 1958 GB
962038 Jun 1964 GB
2074838 Nov 1981 GB
662737 Mar 1994 JP
11171249 Jun 1999 JP
20140031693 Mar 2014 KR
9212660 Aug 1992 WO
0145616 Jun 2001 WO
03082065 Oct 2003 WO
2004083071 Sep 2004 WO
2009114119 Sep 2009 WO
2010013146 Feb 2010 WO
2010066705 Jun 2010 WO
2010085824 Aug 2010 WO
2011095518 Aug 2010 WO
201006516 Sep 2010 WO
2010137956 Dec 2010 WO
2012031106 Mar 2012 WO
2012069505 May 2012 WO
2014056862 Apr 2014 WO
2014112556 Dec 2014 WO
Non-Patent Literature Citations (1)
Entry
International Search Report & Written Opinion in PCT/CA2014/050800 dated Nov. 21, 2014.
Related Publications (1)
Number Date Country
20150056340 A1 Feb 2015 US
Provisional Applications (1)
Number Date Country
61867819 Aug 2013 US